Beximco Pharma Posts Rise In Q3 Pretax Profit
Beximco Pharmaceuticals Limited reported a rise in its Q3 pretax profit.
Its revenue for the quarter rose to Tk2.43 million, from Tk2.15 million, in the year-ago period. Its pretax profit climbed to Tk580,836, from Tk513,597, while EPS gained to Tk1.38, from Tk1.30.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.